Journals / Turkish Journal of Chemistry / 2016 / Cilt: 40 - Sayı: 4

Synthesis of novel thiazolylpyrazoline derivatives and evaluation of theirantimicrobial activities and cytotoxicities

Pages
641–654
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Compound7cshowed the highest antimicrobial activity, possessing the same potential as chloramphenicolagainstK. pneumonia,P. aeruginosa, andE. coli(ATCC-25923).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Several novel thiazolylpyrazoline derivatives were synthesized by reacting substituted 3,5-diaryl-1-thiocarba-moyl-2-pyrazolines with phenacylbromides.
📊
Key Findings & Data:The structures of the synthesized compounds were con rmed by IR,1HNMR,13C NMR, and MS spectral data.
💡
Conclusion & Impact:Compound7cshowed the highest antimicrobial activity, possessing the same potential as chloramphenicolagainstK. pneumonia,P. aeruginosa, andE. coli(ATCC-25923).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Several novel thiazolylpyrazoline derivatives were synthesized by reacting substituted 3,5-diaryl-1-thiocarba-moyl-2-pyrazolines with phenacylbromides. The structures of the synthesized compounds were con rmed by IR,1HNMR,13C NMR, and MS spectral data. Their antimicrobial activities againstStaphylococcus aureus(ATCC-25923),En-terococcus faecalis(ATCC-29212),Enterococcus faecalis(ATCC-51922),Listeria monocytogenes(ATCC-1911),Klebsiellapneumoniae(ATCC-700603),Pseudomonas aeruginosa(ATCC-27853),Escherichia coli(ATCC-35218),Escherichia coli(ATCC-25922),Candida albicans(ATCC-90028),Candida glabrata(ATCC-90030),Candida krusei(ATCC-6258), andCandida parapsilosis(ATCC-22019) were investigated. The compounds were also studied for their cytotoxic effects usinga MTT assay. Compound7cshowed the highest antimicrobial activity, possessing the same potential as chloramphenicolagainstK. pneumonia,P. aeruginosa, andE. coli(ATCC-25923).

🔖

Cite This Article

KAPLANCIKLI, Z. A., BAYSAL, M., YURTTAŞ, L., CANTÜRK, Z., TEBBANI, D., ATLI, Ö., TURAN-ZITOUNI, G., TABBI, A. (2022). Synthesis of novel thiazolylpyrazoline derivatives and evaluation of theirantimicrobial activities and cytotoxicities. Turkish Journal of Chemistry, Cilt: 40 - Sayı: 4, 641–654. https://ajindex.com/articles/602002

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Hawkey, P. M.; Jones, A. M.J. Antimicrob. Chemother.2009,64, i3-i10. 2.Spellberg, B.; Powers, J. H.; Brass, E. P.; Miller, L. G.; Edwards, J. E.Clin. Infect. Dis.2004,38, 1279-1286. 3.Gwynn, M. N.; Portnoy, A.; Rittenhouse, S. F.; Payne, D. J.Ann. N.Y. Acad. Sci.2010,1213, 5-19. 4.Blondelle, S. E.; Perez-Paya, E.; Houghten, R. A.Antimicrob. Agents Chemother.1996,40, 1067-1071. 5.Padmavathi, V.; Thriveni, P.; Sudhakar Reddy, G.; Deepti, D.Eur. J. Med. Chem.2008,43, 917-924. 6.Marella, A.; Ali, M. R.; Alam, M. T.; Saha, R.; Tanwar, O.; Akhter, M.; Shaquiquzzaman, M.; Alam, M. M.Mini.Rev. Med. Chem.2013,13, 921-924. 7.Sharma, S.; Kaur, S.; Bansal, T.; Gaba, J.Chem. Sci. Trans.2014,3, 861-875. 8.Kashyap, S. J.; Garg, V. K.; Sharma, P. K.; Kumar, N.; Dudhe, R.; Gupta, J. K.Med. Chem. Res.2012,21,2123-2132, 9.Dawane, B. S.; Konda, S. G.; Mandawad, G. G.; Shaikh, B. M.Eur. J. Med. Chem.2010,45, 387-392. 10.El-Sabbagh, O. I.; Baraka, M. M.; Ibrahim, S. M.; Pannecouque, C.; Andrei, G.; Snoeck, R.; Balzarini, J.; Rashad,A. A.Eur. J. Med. Chem.2009,44, 3746-3759. 11.Aggarwal, R.; Kumar, S.; Kaushik, P.; Kaushik, D.; Gupta, G. K.Eur. J. Med. Chem.2013,62, 508-514. 12.Budakoti, A.; Bhat, A. R.; Azam, A.Eur. J. Med. Chem.2009,44, 1317-1325. 13.Wang, H. H.; Qiu, K. M.; Cui, H. E.; Yang, Y. S.; Luo, Y.; Xing, M.; Qiu, X. Y.; Bai, L. F.; Zhu, H. L.Bioorg.Med. Chem.2013,21, 448-455. 14.Yang, Y. S.; Zhang, F.; Gao, C.; Zhang, Y. B.; Wang, X. L.; Tang, J. F.; Sun, J.; Gong, H. B; Zhu, H. L.Bioorg.Med. Chem. Lett.2012,22, 4619-4624. 15.Lv, P. C.; Li, D. D.; Li, Q. S.; Lu, X.; Xiao, Z. P.; Zhu, H. L.Bioorg. Med. Chem. Lett.2011,21, 5374-5377. 16.Mandawad, G. G.; Dawane, B. S.; Beedkar, S. D.; Khobragade, C. N.; Yemul, O. S.Bioorg. Med. Chem.2013,21,365-372. 17.Sulthana, S. S.; Antony, S. A.; Balachandran, C.; Sha, S. S.Bioorg. Med. Chem. Lett.2015,25, 2753-2757. 18.Bano, S.; Alam, M. S.; Javed, K.; Dudeja, M.; Das, A. K.; Dhulap, A.Eur. J. Med. Chem.2015,95, 96-103. 19.Turan-Zitouni, G.; Chevallet, P.; Kilic, F. S.; Erol, K.Eur. J. Med. Chem.2000,35, 635-641. 20.Turan-Zitouni, G.;Ozdemir, A.; Guven, K.Arch. Pharm. Chem. Life Sci.2005,338, 96-104. 21.Turan-Zitouni, G.;Ozdemir, A.; Kaplanckl, Z. A.; Chevallet, P.; Tunal, Y.Phosphorus Sulfur Silicon Relat.Elem.2005,180, 2717-2724. 22.Kaplanckl, Z. A.; Turan-Zitouni, G.;Ozdemir, A.; Revial, G.; Guven, K.Phosphorus Sulfur Silicon Relat. Elem.2007,182, 749-764. 23.Ozdemir, A.; Turan-Zitouni, G.; Kaplanckl, Z. A.; R